Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,037.81 -1,239.64 (-1.93%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
EastWest Bioscience Inc. (HBOSF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:49PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 10.07k |
| Enterprise value | 1.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.05 |
| Price/book (mrq) | 0.00 |
| Enterprise value/revenue | 6.12 |
| Enterprise value/EBITDA | 4.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | 0.00% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 0.0001 |
| 52-week low 3 | 0.0001 |
| 50-day moving average 3 | 0.0001 |
| 200-day moving average 3 | 0.0001 |
Share statistics
| Avg vol (3-month) 3 | 315 |
| Avg vol (10-day) 3 | 315 |
| Shares outstanding 5 | 92.61M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 70.86M |
| % held by insiders 1 | 31.00% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | N/A |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CAD.Fiscal year
| Fiscal year ends | 31 Jul 2021 |
| Most-recent quarter (mrq) | 30 Apr 2022 |
Profitability
| Profit margin | 15.44% |
| Operating margin (ttm) | -69.16% |
Management effectiveness
| Return on assets (ttm) | -27.80% |
| Return on equity (ttm) | -0.04% |
Income statement
| Revenue (ttm) | 703.1k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -17.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -2.28M |
| Net income avi to common (ttm) | 108.55k |
| Diluted EPS (ttm) | 0.0040 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 19.97k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 2.46M |
| Total debt/equity (mrq) | 71.67% |
| Current ratio (mrq) | 0.09 |
| Book value per share (mrq) | 0.03 |
Cash flow statement
| Operating cash flow (ttm) | -400.49k |
| Levered free cash flow (ttm) | -555.63k |
© 2024 Yahoo. All rights reserved.